日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort Study

C反应蛋白动力学作为日本人群中接受免疫检查点抑制剂治疗的IV期黑色素瘤患者的预后生物标志物：一项单中心回顾性队列研究

期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.70002
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
Checkpoint
黑色素瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study

改良格拉斯哥预后评分在接受免疫检查点抑制剂治疗的IV期黑色素瘤患者中的预后意义：一项单中心回顾性研究

期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.70131
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
Checkpoint
黑色素瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Comparison of Adjuvant and Salvage Therapy with Immune Checkpoint Inhibitors in Head and Neck Mucosal Melanoma Treated with Proton Beam Therapy: A Retrospective Cohort Study

质子束治疗头颈部黏膜黑色素瘤辅助治疗与挽救治疗联合免疫检查点抑制剂的比较：一项回顾性队列研究

期刊:Acta Dermato-Venereologica
影响因子:3.7
doi:10.2340/actadv.v105.43602
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
Checkpoint
发表日期：2025
文献求助 收藏

Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective study

比较日本黑色素瘤患者接受纳武利尤单抗和伊匹木单抗治疗不同疗程的疗效和不良事件：一项单中心回顾性研究

期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.17672
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
黑色素瘤
发表日期：2025
文献求助 收藏

Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 Monotherapy

根据最佳肿瘤负荷变化对接受一线程序性细胞死亡蛋白1单药治疗的日本晚期黑色素瘤患者的预后和毒性进行分层分析

期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.17938
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
黑色素瘤
肿瘤
肿瘤免疫
细胞生物学
毒理研究
发表日期：2025
文献求助 收藏

Prognostic value of the CONUT score with immune checkpoint inhibitors as first-line therapy for metastatic malignant melanoma

CONUT评分在免疫检查点抑制剂作为转移性恶性黑色素瘤一线治疗中的预后价值

期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.17613
Horisaki, Ken; Yoshikawa, Shusuke; Mori, Shoichiro; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
黑色素瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Predictors of Dermal Invasion and Sentinel Lymph Node Metastasis in Patients With Extramammary Paget's Disease Without Clinical Lymph Node Enlargement

无临床淋巴结肿大的乳房外Paget病患者真皮浸润和前哨淋巴结转移的预测因素

期刊:Journal of Dermatology
影响因子:2.7
doi:10.1111/1346-8138.17795
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
发表日期：2025
文献求助 收藏

Normal Variance Mixture with Arcsine Law of an Interpolating Walk Between Persistent Random Walk and Quantum Walk

正态方差混合模型，具有反正弦定律，用于描述持续随机游走和量子游走之间的插值游走。

期刊:Entropy
影响因子:2
doi:10.3390/e27070670
Yoshino, Saori; Shiratori, Honoka; Yamagami, Tomoki; Horisaki, Ryoichi; Segawa, Etsuo
发表日期：2025
文献求助 收藏

Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort study

日本患者外阴和阴道恶性黑色素瘤的临床特征及免疫检查点抑制剂疗效：一项单中心回顾性队列研究

期刊:Melanoma Research
影响因子:1.9
doi:10.1097/CMR.0000000000001012
Horisaki, Ken; Yoshikawa, Shusuke; Omata, Wataru; Tsutsumida, Arata; Kiyohara, Yoshio
黑色素瘤
免疫/内分泌
发表日期：2025
文献求助 收藏

Conflict-free joint decision by lag and zero-lag synchronization in laser network

激光网络中基于滞后和零滞后同步的无冲突联合决策

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-54491-1
Ito, Hisako; Mihana, Takatomo; Horisaki, Ryoichi; Naruse, Makoto
发表日期：2024
文献求助 收藏